2023
DOI: 10.1016/j.coi.2023.102356
|View full text |Cite
|
Sign up to set email alerts
|

Major histocompatibility complex class I assembly within endolysosomal pathways

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 70 publications
0
1
0
Order By: Relevance
“…Suboptimal loading with low-affinity peptides affects pMHC-I stability and leads to retention of MHC-I molecules in the secretory and recycling pathways. Thus, manipulation of pMHC-I biogenesis by deletion, downregulation, or mutation of PLC components leads to a reduction of MHC-I molecules on the cell surface—a process, utilized by many viruses and cancer cells to evade immune surveillance ( 2 , 21 27 ). However, the impact of individual PLC components on the quantity of MHC-I surface molecules, especially of different MHC-I allomorphs, and the effect on the presentation of defined pMHC-I complexes are not yet fully elucidated.…”
mentioning
confidence: 99%
“…Suboptimal loading with low-affinity peptides affects pMHC-I stability and leads to retention of MHC-I molecules in the secretory and recycling pathways. Thus, manipulation of pMHC-I biogenesis by deletion, downregulation, or mutation of PLC components leads to a reduction of MHC-I molecules on the cell surface—a process, utilized by many viruses and cancer cells to evade immune surveillance ( 2 , 21 27 ). However, the impact of individual PLC components on the quantity of MHC-I surface molecules, especially of different MHC-I allomorphs, and the effect on the presentation of defined pMHC-I complexes are not yet fully elucidated.…”
mentioning
confidence: 99%